[go: up one dir, main page]

AR057933A1 - DEPIGMENTING PHARMACEUTICAL COMPOSITION INCLUDING N- (2 - ((3- (4- BROMOFENIL) - 2- PROPENIL) AMINO) ETIL) -5- ISOQUINOLINSULFONAMIDE (H89) - Google Patents

DEPIGMENTING PHARMACEUTICAL COMPOSITION INCLUDING N- (2 - ((3- (4- BROMOFENIL) - 2- PROPENIL) AMINO) ETIL) -5- ISOQUINOLINSULFONAMIDE (H89)

Info

Publication number
AR057933A1
AR057933A1 ARP060105185A ARP060105185A AR057933A1 AR 057933 A1 AR057933 A1 AR 057933A1 AR P060105185 A ARP060105185 A AR P060105185A AR P060105185 A ARP060105185 A AR P060105185A AR 057933 A1 AR057933 A1 AR 057933A1
Authority
AR
Argentina
Prior art keywords
isoquinolinsulfonamide
depigmenting
amino
pharmaceutical composition
bromofenil
Prior art date
Application number
ARP060105185A
Other languages
Spanish (es)
Inventor
Corine Bertolotto
Robert Ballotti
Flavio Luciani
Mehdi Khaled
Original Assignee
Galderma Res & Dev
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Inst Nat Sante Rech Med filed Critical Galderma Res & Dev
Publication of AR057933A1 publication Critical patent/AR057933A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Composicion farmacéutica despigmentante que comprende una cantidad eficaz de N-[2-[[3-(4-bromofenil)-2-propenil]amino]etil]-5-isoquinolinsulfonamida (H89) en un soporte farmacéuticamente aceptable.Depigmenting pharmaceutical composition comprising an effective amount of N- [2 - [[3- (4-bromophenyl) -2-propenyl] amino] ethyl] -5-isoquinolinsulfonamide (H89) in a pharmaceutically acceptable carrier.

ARP060105185A 2005-11-25 2006-11-24 DEPIGMENTING PHARMACEUTICAL COMPOSITION INCLUDING N- (2 - ((3- (4- BROMOFENIL) - 2- PROPENIL) AMINO) ETIL) -5- ISOQUINOLINSULFONAMIDE (H89) AR057933A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511977A FR2893841B1 (en) 2005-11-25 2005-11-25 DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)

Publications (1)

Publication Number Publication Date
AR057933A1 true AR057933A1 (en) 2007-12-26

Family

ID=36934164

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105185A AR057933A1 (en) 2005-11-25 2006-11-24 DEPIGMENTING PHARMACEUTICAL COMPOSITION INCLUDING N- (2 - ((3- (4- BROMOFENIL) - 2- PROPENIL) AMINO) ETIL) -5- ISOQUINOLINSULFONAMIDE (H89)

Country Status (3)

Country Link
AR (1) AR057933A1 (en)
FR (1) FR2893841B1 (en)
WO (1) WO2007060182A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112903657B (en) * 2021-01-28 2022-06-24 中山大学 A kind of surface-enhanced Raman spectroscopy detection method of melamine and formaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835252B1 (en) * 2002-01-25 2005-08-05 Seppic Sa USE OF A PROTEIN KINASE A INACTIFYING COMPOUND IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM FOR LAMINATING THE SKIN
US7256200B2 (en) * 2003-02-10 2007-08-14 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Method and composition for potentiating an oplate analgesic

Also Published As

Publication number Publication date
FR2893841B1 (en) 2014-04-25
FR2893841A1 (en) 2007-06-01
WO2007060182A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
NO2019005I1 (en) N- [2- (diethylamino) ethyl] -5 - [(Z) - (5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene) methyl] -2,4-dimethyl- 1H-pyrrole-3-carboxamide (sunitinib), as well as pharmaceutically acceptable salts
DK1478399T3 (en) ORAL DOSAGE FORM CONTAINING A PDE-4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINYLPYRROLIDONE AS EXCIPIENT
CY1109523T1 (en) PHARMACEUTICAL COMPOSITION comprising a benzodiazepine derivative and an RSV Fusion Inhibitor
CY2016042I1 (en) NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS
PE20081187A1 (en) ANG2 AND VEGF INHIBITOR COMBINATIONS
NO20043722L (en) Pharmaceutical compositions for hepatitis C virus protease inhibitors
IL225167A (en) (p-methoxy)phenyl-sulfonamide, n-(i-butyl), n-[(2r)-hydroxy-(3r)-benzyl-propyl] derivatives
UY28330A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A HISTONE DEACETILASE INHIBITOR
LU93093I2 (en) NECITUMUMAB AND ITS PHARMACEUTICALLY ACCEPTABLE DERIVATIVES (PORTRAZZA)
NO20041709L (en) N-substituted pyrrolidine derivatives as dipeptidyl peptidase IV inhibitors
BRPI0113669B8 (en) n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]-amino]methyl]phenyl]-2e-2-propenamide, pharmaceutical composition comprising the same and use
GEP20074047B (en) Pramipexole once-daily dosage form
CL2007000918A1 (en) COMPOUNDS DERIVED FROM ENFUMAFUNGINA, INHIBITORS OF (1,3) -BETA-D-GLUCANOSINTETASE; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A FUNGICAL INFECTION.
DK1542970T3 (en) Pyrrolidine derivatives as MAOB inhibitors
BRPI0507652A (en) pharmaceutical compositions comprising a benzoidiazepine derivative and an rsv fusion protein inhibitor
MXPA05007609A (en) CaSR ANTAGONIST.
UY30403A1 (en) SALTS OF N-HYDROXI-3- [4 - [[[2- (2-METHYL-1H-INDOL-3-IL) ETHYL] AMINO] PHENYL] -2E-2-PROPENAMIDE
AR044155A1 (en) COMBINATION THAT INCLUDES 2- S- [2 - ({[1- (2 - ETHYLBUTY) CYCLHEXYL) CARBONYL} AMINO) PHENYL] METHYLROPANOTIOATE AND A HMG COA REDUCTASE INHIBITOR
CL2007001689A1 (en) SUBSTANTIELY PURE CRYSTAL FORMS OF N-HYDROXY-3- [4 - [[[2- (2-METHYL-1H-INDOL-3-IL) ETHYL] AMINO] METHYL] PHENYL] -2E-2-PROPENAMIDE; PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT AN ILLNESS THAT RESPONDS TO AN INHIBITION OF PROT KINASE ACTIVITY
EA200401515A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN IN POLYMORPHIC MODIFICATION A
GEP20104878B (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
ECSP088957A (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL AND METHOD FOR MANUFACTURING
DK1268419T3 (en) Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
PE20061373A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 'N- (2-CHLORO-6-METHYLPHENIL) -2 - [[6- [4- (2-HYDROXYETHYL) -1-PIPERAZINYL] -2-METHYL-4-PYRIMIDINYL] AMINO] -5- THIAZOLCARBOXAMIDE
AR059045A1 (en) PHARMACEUTICAL COMPOSITION AND PROCESS

Legal Events

Date Code Title Description
FB Suspension of granting procedure